Therapy preference and decision-making among patients with severe sickle cell anemia and their families

scientific article published on June 2007

Therapy preference and decision-making among patients with severe sickle cell anemia and their families is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/PBC.20903
P698PubMed publication ID16732581

P50authorPamela S. HindsQ88238145
P2093author name stringChin-Shang Li
Winfred Wang
Jane Hankins
Yvonne Carroll
Sara Day
Patricia Garvie
P2860cites workPhysician recommendations and patient autonomy: finding a balance between physician power and patient choiceQ41224115
P433issue7
P921main subjectsickle-cell diseaseQ185034
decision makingQ1331926
P304page(s)705-710
P577publication date2007-06-01
P1433published inPediatric Blood & CancerQ15754342
P1476titleTherapy preference and decision-making among patients with severe sickle cell anemia and their families
P478volume48

Reverse relations

cites work (P2860)
Q88440631A Retrospective Analysis of Sociodemographic and Hematologic Characteristics Associated With Achieving Optimal Hydroxyurea Therapy in Children With Sickle Cell Disease
Q33440495A pilot study of electronic directly observed therapy to improve hydroxyurea adherence in pediatric patients with sickle-cell disease
Q37622209A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease
Q33876417Adherence to hydroxyurea, health-related quality of life domains, and patients' perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults.
Q91639061American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease
Q36860550Barriers to hematopoietic cell transplantation clinical trial participation of african american and black youth with sickle cell disease and their parents
Q45150943Bone marrow transplant options and preferences in a sickle cell anemia cohort on chronic transfusions
Q91681227Comparative Effectiveness of a Web-Based Patient Decision Aid for Therapeutic Options for Sickle Cell Disease: Randomized Controlled Trial
Q48154699Decision making in pediatric hematopoietic cell transplantation: Influential factors vary among diseases.
Q90464611Development of a Hydroxyurea Decision Aid for Parents of Children With Sickle Cell Anemia
Q35599915Examining the characteristics and beliefs of hydroxyurea users and nonusers among adults with sickle cell disease.
Q55513319From trust to skepticism: An in-depth analysis across age groups of adults with sickle cell disease on their perspectives regarding hydroxyurea.
Q35072375Health-related quality of life in children and adolescents with sickle cell disease
Q38004362Health-related quality of life in sickle cell disease: past, present, and future
Q33985120How I use hydroxyurea to treat young patients with sickle cell anemia
Q35754065Hydroxyurea therapy for children with sickle cell disease: describing how caregivers make this decision
Q37223344Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities
Q91827723Identification of therapeutic targets for inflammation in sickle cell disease (SCD) among Indian patients using gene expression data analysis
Q26779359Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease
Q36169208Longitudinal Analysis of Patient Specific Predictors for Mortality in Sickle Cell Disease.
Q37321275Making decisions about chronic disease treatment: a comparison of parents and their adolescent children
Q37888719Stem-cell transplantation in children and adults with sickle cell disease: an update
Q91716403Targeted Hydroxyurea Education after an Emergency Department Visit Increases Hydroxyurea Use in Children with Sickle Cell Anemia
Q38176054The case for and against initiating either hydroxyurea therapy, blood transfusion therapy or hematopoietic stem cell transplant in asymptomatic children with sickle cell disease
Q50908811Trade-off between survival and laryngeal preservation in advanced laryngeal cancer: the otorhinolaryngology patient's perspective.
Q27314693Understanding and improving health education among first-time parents of infants with sickle cell anemia in Alabama: a mixed methods approach
Q28083007Update of hematopoietic cell transplantation for sickle cell disease
Q37130153What is known about parents' treatment decisions? A narrative review of pediatric decision making

Search more.